fluconazole has been researched along with Encephalopathy, Hepatic in 4 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krashin, E | 2 |
| Lishner, M | 2 |
| Chowers, M | 2 |
| Reisfeld, S | 2 |
| Kung, N | 1 |
| Fisher, N | 1 |
| Gunson, B | 1 |
| Hastings, M | 1 |
| Mutimer, D | 1 |
| Bronstein, JA | 1 |
| Gros, P | 1 |
| Hernandez, E | 1 |
| Larroque, P | 1 |
| Molinié, C | 1 |
4 other studies available for fluconazole and Encephalopathy, Hepatic
| Article | Year |
|---|---|
Candida albicans in peritoneal fluid in a patient with hepatic encephalopathy.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Antifungal Agents; Ascites; Ascitic Fluid; beta- | 2014 |
Candida albicans in peritoneal fluid in a patient with hepatic encephalopathy.
Topics: Antifungal Agents; Ascitic Fluid; Candida albicans; Escherichia coli; Fatal Outcome; Female; Flucona | 2015 |
Fluconazole prophylaxis for high-risk liver transplant recipients.
Topics: Adult; Candidiasis; Fluconazole; Hepatic Encephalopathy; Humans; Liver Diseases; Liver Transplantati | 1995 |
Fatal acute hepatic necrosis due to dose-dependent fluconazole hepatotoxicity.
Topics: Aged; Aged, 80 and over; Candidiasis; Dose-Response Relationship, Drug; Fatal Outcome; Fluconazole; | 1997 |